SCTR
Secretin receptor
As of the edition of 20 October 2026, SCTR (secretin receptor, UniProt P47872) has 3 drugs tested at it and 1 company on the list, 0 on route A and 0 on route B.
Sources: UniProt, ClinicalTrials.gov, ChEMBL, FDA Orange Book and Purple Book, Pharos.
The protein
- UniProt
- P47872
- How well studied
- Drug target: an approved drug acts on it
- Where it sits in the cell
- At a membrane
- Solved structures
- 3
- Disease areas
- Digestive system; Hormones; Cancer; Nutrition and metabolism; Inherited and neonatal; Mental health; Skin and connective tissue; Immune system
- Registered trials of its drugs
- 19
Drugs at this target
| Status | Count |
|---|---|
| Marketed | 3 |
| Total | 3 |
| Drug | Status | Furthest phase | US protection |
|---|---|---|---|
| Secretin | Marketed | Phase 4 | none listed |
| Secretin synthetic human | Marketed | Phase 3 | none listed |
| Secretin synthetic porcine | Marketed | Phase 3 | none listed |
3 of 3 drugs, the most tested first.
Companies at this target
| Where the company stands | Companies |
|---|---|
| Undetermined | 1 |
| Total on the list | 1 |